Skip to main content

Search
Profile

Sandra E. Juul, MD, PhD

|
Sandra E. Juul, MD, PhD

Neonatology

On staff since July 2000

Children's Title: Director, Neonatology Fellowship; Associate Division Chief, Research and Scholarship

Academic Title: Professor of Pediatrics

Research Center: Center for Integrative Brain Research

"As a neonatologist, I am privileged to participate in the care of the most precious, fragile individuals. These small patients and their families often humble me with their insights and endurance in the face of great adversity. I believe that my role as an academic neonatologist is to bring the field forward by focusing on specific clinical problems and, through research efforts, to try to solve or shed light on them. My research focuses on neonatal neuroprotection: how to protect the brain from injury, and how to repair the injured brain."

Overview

Board Certification(s)
Pediatrics
Neonatal-Perinatal Medicine
Medical/Professional School
University of Washington School of Medicine, Seattle
University of Chicago, Chicago
Residency
Pediatrics, University of Washington School of Medicine, Seattle
Fellowship
Neonatal-Perinatal Medicine, Seattle Children's Hospital, Seattle
Clinical Interests

Non-hematopoietic effects of erythropoietin (Epo), particularly its neuroprotective effects. Hematopoiesis and iron balance in preterm infants are additional areas of interest and research.

Research Description

Recombinant erythropoietin (rEpo) has been used since 1989 as an erythropoietic agent in adults and children. More recently, Epo effects have been recognized in tissues other than bone marrow. Functional receptors for Epo are present in the developing brain, liver, heart, blood vessels, and intestine.

During development, endogenous Epo acts as a general trophic and anti-apoptotic factor. Mechanisms of Epo action are being investigated. Two promising areas of research include the use of rEpo to prevent or ameliorate necrotizing enterocolitis, and the use of rEpo to decrease brain damage following injury such as perinatal hypoxia-ischemia.

Using a variety of molecular biology, cell and tissue culture techniques, and in vivo models, Dr. Juul's research is focused on determining the effects of Epo on neurodevelopment, neuroprotection, intestinal development, and intestinal injury. Additional areas of interest include neonatal hematology, and iron deficiency in the developing neonate.

Research Focus Area

Neuroscience / Neurodevelopment

Awards and Honors

Award NameAward DescriptionAwarded ByAward Date
SEATTLE'S TOP DOCTOR - 2014Seattle Metropolitan Magazine 2014

Publications

Systemic glycerol decreases neonatal rabbit brain and cerebellar growth independent of intraventricular hemorrhage.
Pediatric research , 2014 Mar: 75(3)389-94
Systemic glycerol decreases neonatal rabbit brain and cerebellar growth independent of intraventricular hemorrhage.
Pediatric research , 2013 Dec 17
Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.
American journal of primatology , 2013 Nov: 75(11)1063-83
Erythropoietin Improved Cognitive Function and Decreased Hippocampal Caspase Activity in Rat Pups after Traumatic Brain Injury.
Journal of neurotrauma , 2013 Aug 25
Adult responses to an ischemic stroke in a rat model of neonatal stress and morphine treatment.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience , 2013 Feb: 31(1)25-9
Hypothermia plus erythropoietin for neonatal neuroprotection? Commentary on Fan et al. and Fang et al.
Pediatric research , Jan. 2013: 73(1)10-1
Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.
Methods in molecular biology (Clifton, N.J.) , 2013: 982113-26
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
Developmental neuroscience , 2013: 35491-503
Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.
Methods in molecular biology (Clifton, N.J.) , 2013: 982113-26
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
Developmental neuroscience , 2013: 35(6)491-503
Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.
Methods in molecular biology (Clifton, N.J.) , 2013: 982113-26
Hypothermia plus erythropoietin for neonatal neuroprotection? Commentary on Fan et al. and Fang et al.
Pediatric research , 2013 Jan: 73(1)10-1
Erythropoiesis and the approach to anemia in premature infants.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians , Oct. 2012: 25(Suppl 5)97-9
Erythropoietin in anemia of prematurity.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians , Oct. 2012: 25(Suppl 5)80-4
Neuroprotective role of erythropoietin in neonates.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians , Oct. 2012: 25 Suppl 4105-7
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
Pediatrics , Oct. 2012: 130(4)683-91
Erythropoiesis and the approach to anemia in premature infants.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians , 2012 Oct: 25(Suppl 5)97-9
Neuroprotective role of erythropoietin in neonates.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians , 2012 Oct: 25 Suppl 4105-7
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
Pediatrics , 2012 Oct: 130(4)683-91
Zinc protoporphyrin-to-heme ratios in high-risk and preterm infants.
The Journal of Pediatrics , July 2012: 161(1)81-7.e1
Cell therapy for neonatal hypoxia-ischemia and cerebral palsy.
Annals of neurology , May 2012: 71(5)589-600
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?
The Journal of pediatrics , April 2012: 160(4)544-552.e4
The perinatal transition of the circulating metabolome in a nonhuman primate.
Pediatric research , April 2012: 71(4 Pt 1)338-44
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?
The Journal of pediatrics , 2012 Apr: 160(4)544-552.e4
Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesis.
Behavioural brain research , Feb. 2012: 227(1)7-11
The role of cytokines and inflammatory cells in perinatal brain injury.
Neurology research international , 2012: 2012561494

Presentations

Presentations TitleEventLocationDate
DANCE (Darbe Administration In Newborns Undergoing Cooling For Encephalopathy): Safety And Pharmacokinetic TrialWSPR 2014 Platform presentation 2014
Can we improve the outcome of prematurity?Grand Rounds at the University of New Mexico Department of PediatricsNov. 14, 2013
Can we improve the outcome of prematurity?Grant Rounds at Amplatz Childrens Hospital Sept. 25, 2013
History of Neonatology - Whats new in HIE?Childrens Hospital of MinneapolisMinneapolis, MinnesotaSept. 24, 2013
Can we improve the outcome of prematurity?Newborn Medicine Grand Rounds for the Harvard Program in NeonatologyBoston Childrens HospitalSept. 9, 2013
Can we improve the outcome of prematurity?UT Southwestern Pediatric Grand RoundsApril 17, 2013
Brain injury in the preterm infant: can we improve outcomes?Australian Neuroscience Society (ANS)Feb. 6, 2013
Erythropoietin (EPO) With Hypothermia (Ht) Provides Improved Neuroprotection In A Nonhuman Primate Model Of Perinatal AsphyxiaPAS 2013 Platform Presentation 2013
Metabolomic profiles after perinatal asphyxia (PA) and correlations with neurodevelopment outcomes in a nonhuman primate model.PAS Poster 2013 2013
DANCE (Darbe Administration In Newborn Undergoing Cooling for Encephalopathy):Safety And Pharmacokinetic Trial.WSPR 2014 Platform Presentation 2013
Erythropoietin (Epo) With Hypothermia (Ht) Provides Improved Neuroprotection In A Nonhuman Primate Model Of Perinatal AsphyxiaPAS 2013 Platform presentation 2013
Neuroprotective role of EpoNational Congress of Italian Society of Neonatology (SIN) Rome, ItalyOct. 3, 2012 - Oct. 6, 2012
Erythropoiesis and the approach to anemia of prematurity; The ultimate word on the use of Erythropoietin in anemia of prematuritySeminars in Neonatal HematologyBari, ItalyOct. 1, 2012 - Oct. 2, 2012
Biomarkers of neonatal encephalopathy in a nonhuman primate model2012 Northwest Metabolomics Research Center Metabolomics SymposiumSept. 14, 2012
a.Neonatal Iron Balance: What does it matter? b.Transfusions in the NICU: Is more better? c. Epo Neuroprotection: Is this the next cool thing? d.Neonatal Sedation: What is on the horizon?IpokratesLecco, ItalyMay 24, 2012 - May 26, 2012
Erythropoietin: Is this the next cool neuroprotectant?California Association of Neonatologists (CAN)March 2012
Erythropoietin: Is this the next cool neuroprotectant?MidAtlantic Neonatology meetingMarch 2012
Phase I Trial Of Neonatal Erythropoietin In Perinatal Hypoxic-Ischemic EncephalopathyWSPR 2012 Platform presentation. 2012
A Case Study of Cerebral Palsy (CP) after Neonatal Encephalopathy (NE) in a Macaque ModelPAS Poster 2012 2012
Use of diffusion tensor images as biomarkers of neonatal encephalopathy using a macaque model33rd Western Conference on Perinatal ResearchIndian Wells CA 2012
Therapeutic Hypothermia Plus Erythropoietin Alters Early MRI Findings after Perinatal Asphyxia in a Macaque ModelPAS Platform Presentation 2012 2012
Phase I Trial Of Neonatal Erythropoietin In Perinatal Hypoxic-Ischemic EncephalopathyPAS 2012 Platform presentation 2012

Research Funding

Grant TitleGrantorAmountAward Date
Biomarkers of brain injury and inflammation in perinatal hypoxic ischaemic encephalopathy.Innovative Research Grant, CP Alliance. $120,000Jan. 2, 2014 - Jan. 1, 2015
Neonatal Erythropoietin and Therapeutic Hypothermia Outcomes Study (NEAT O).Thrasher FoundationSept. 1, 2013 - Aug. 30, 2015
Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) CCC.NINDS 1U01NS077953-01 $10,255,370July 1, 2013 - June 30, 2018
Biomarkers of neonatal encephalopathy in a nonhuman primate model.NICHD 1 R01 HD073128-01A1 $2,496,627July 1, 2013 - June 30, 2018
DANCE trial. Darbepoietin Administration in Newborns Undergoing Cooling for EncephalopathyThrasher Grant $45,252 2012 - 2014
A Novel Non-Human Primate Model of Neonatal Stress and Sedative Drug Use.Institute of Translational Health Sciences $67500 2010 - 2012
ARRA supplement to R01-HD-52820-01A3NICHD $204100 2009 - 2012

Primary Office

University of Washington
UW Box 356320 - Neonatology
1959 NE Pacific St
Seattle, WA 98195-6320
206-543-3200

Additional Offices

Seattle Children's
M1-12 - NICU Administration
4800 Sand Point Way NE
Seattle, WA 98105
206-987-2041

Find a Doctor or Researcher

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

Doctor or Researcher Name:

More search options